CIK 0001841387
- Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522214851
- Phone
- +1 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,160,783
- in 1 filing, $3.2M under 10b5-1 plans
Net −$3,160,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +2,189 | $8.68 | $19K | 2,189 |
| 2026-06-30 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +2,199 | $8.64 | $19K | 2,199 |
| 2026-06-23 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2026-03-31 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +4,618 | $4.11 | $19K | 4,618 |
| 2026-02-23 | Manning Paul B Director | Purchase | +550,458 | $5.45 | $3.0M | 2,763,527 |
| 2025-06-25 | Manning Paul B Director | Grant or award | +1,070,663 | $4.67 | $5.0M | 2,213,069 |
| 2025-06-17 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2024-12-16 | Manning Paul B Director | Purchase | +500,000 | $6.00 | $3.0M | 1,142,406 |
| 2024-12-16 | Manning Paul B Director | Purchase | +750,000 | $6.00 | $4.5M | 1,303,752 |
| 2024-06-26 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2023-06-28 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2022-10-13 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2021-07-29 | Manning Paul B Director | Conversion | +679,158 | 679,158 | ||
| 2021-07-29 | Manning Paul B Director | Conversion | +553,752 | 553,752 | ||
| 2021-07-29 | Manning Paul B Director | Purchase | +1,625,000 | $8.00 | $13.0M | 1,681,000 |
| 2021-07-29 | Manning Paul B Director | Conversion · Series B Preferred Stock | −1,669,303 | 0 | ||
| 2021-07-29 | Manning Paul B Director | Conversion · Series B Preferred Stock | −1,361,069 | 0 | ||
| 2021-07-29 | Manning Paul B Director | Conversion | +679,158 | 679,158 | ||
| 2021-07-29 | Manning Paul B Director | Conversion | +553,752 | 553,752 | ||
| 2021-07-29 | Manning Paul B Director | Conversion · Series B Preferred Stock | −1,669,303 | 0 |
Page 1 of 2 · 23 trades